Genentech to Speak at 5th Assay Conference Sept 20-21, 2010 San Diego, CA
Laura DeForge, Senior Scientist at Genentech, Inc, will give a presentation on “Real-time Impedance-based Bioassays Using the xCELLigence™ Technology.” at 5th Assay and Drug Discovery Technologies Conference to be held this year in San Diego, CA Sept. 20-21, 2010 by GTCbio. xCELLigence is a cell-based assay platform that allows for real-time, label-free monitoring of cellular responses by measuring electrical impedance. Benefits of xCELLigence include: Real-time data collection over the course of the experiment yields more information than endpoint assays, the...
View full press release